Ellicott City, MD, United States of America

David M Hone

This inventor holds 26 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: University System of Maryland, Aeras Global Tb Vaccine Foundation, Crucell Holland B.v.. Active years: 1999-2013.

USPTO Granted Patents = 26 (Patent Applications = 4)

% Patents Active = 69.2

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 558(Granted Patents)

Location History:

Ellicott City, MD (US) (1999 - 2008)
Rockville, MD (US) (2006 - 2011)
Poolesville, MD (US) (2011)
Bethesda, MD (US) (2012 - 2013)

Company Filing History:

15 out of 2,020

University System of Maryland

patents

10 out of 18

Aeras Global Tb Vaccine Foundation

Leland Stanford Junior University

patents

5. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2013

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8609402 - Multivalent vaccines comprising recombinant viral vectors (2013-12-17),

2. 8202723 - Multivalent vaccines comprising recombinant viral vectors (2012-06-19),

3. 8053568 - Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof (2011-11-08),

4. 8043857 - Recombinant BCG strains with enhanced ability to escape the endosome (2011-10-25),

5. 8012467 - Multivalent vaccines comprising recombinant viral vectors (2011-09-06),

6. 7935354 - [object Object] (2011-05-03),

7. 7850958 - Recombinant double stranded RNA nucleocapsid and use of the same (2010-12-14),

8. 7829104 - [object Object] (2010-11-09),

9. 7666656 - Recombinant BCG strains with enhanced ability to escape the endosome (2010-02-23),

10. 7625572 - Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria (2009-12-01),

11. 7569219 - Recombinant double-stranded RNA phage, and use of the same (2009-08-04),

12. 7537769 - Webbed immunogens comprising recombinant human immunodeficiency virus (HIV) envelope glycoproteins and the M9 scorpion toxin (2009-05-26),

13. 7407790 - Recombinant double-stranded RNA phages and uses thereof (2008-08-05),

14. 7393525 - Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same (2008-07-01),

15. 7125718 - Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same (2006-10-24),

Title: The Innovative Journey of David M Hone

Introduction:

David M Hone, a talented inventor hailing from Ellicott City, MD (US), has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents:

David M Hone's latest patents include cutting-edge innovations in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

Throughout his illustrious career, David M Hone has been recognized for his exceptional problem-solving skills and ability to think outside the box. His inventions have revolutionized various industries, earning him a reputation as a visionary inventor.

Collaborations:

David M Hone has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His partnerships have been instrumental in turning his concepts into tangible products that have had a lasting impact on society.

Conclusion:

In conclusion, David M Hone's passion for innovation and dedication to pushing the boundaries of what is possible have solidified his position as a trailblazing inventor. His work continues to inspire future generations of inventors to dream big and create the technologies of tomorrow.